Over 50 Research Studies by IVI RMA North America Set to Advance Infertility Care at ASRM 2024
IVI RMA North America, which encompasses Reproductive Medicine Associates and Boston IVF, will showcase more than 50 groundbreaking infertility research studies at the American Society for Reproductive Medicine (ASRM) Annual Scientific Congress and Expo in Denver, Colorado, from October 19-23. Over 40 reproductive endocrinologists, scientists, clinicians, and researchers from IVI RMA will present studies that address critical clinical questions, driving innovation, improving clinical processes, and enhancing patient outcomes in the infertility sector.
“Our commitment to researching and improving infertility treatment has led to significant advancements in IVF and the broader field,” stated Dr. Thomas Molinaro, Chief Medical Officer of IVI RMA North America. “The extensive research we will present at ASRM 2024 underscores our dedication to advancing infertility treatment and delivering evidence-based care to as many patients as possible.”
Key Research Highlights:
- A retrospective study analyzing over 40,000 live births from the past 25 years.
- An examination of how male reproductive age affects infertility outcomes.
- An investigation into the possibility of achieving multiple live births from a single ovarian stimulation and egg retrieval cycle.
Christine Whitehead, MS, BSN, RN, Director of Research Operations at IVI RMA North America, noted, “For nearly 30 years, we have been at the forefront of infertility research, contributing thousands of papers and abstracts. We take pride in the innovations and breakthroughs that stem from our efforts.”
Featured Presentations at ASRM 2024:
Oral Abstract Presentations:
- Effects of Intraovarian Platelet-Rich Plasma on Ovarian Response – Shohra Qaderi, MD, 10/21 at 11:07 AM
- Impact of Advanced Sperm Age on Aneuploidy Rates – Francesca Barrett, MBA, MD, 10/21 at 2:14 PM
- Demographic Predictors of Oocyte Utilization – Rachael D’Auria, MD, BS, 10/21 at 12:02 PM
- Cost-Conscious Fertility Care for Same-Sex Couples – Vania Nwokolo, MD, 10/21 at 1:30 PM
- Low Birth Weight Trends in IVF Newborns – Andres Reig, MD, 10/22 at 2:25 PM
Poster Abstracts:
- Cryopreserved vs. Fresh Donor Oocytes – Lea George, MD, 10/21 at 11:30 AM
- Impact of Air Pollution on IVF Outcomes – Blake Vessa, MD, 10/21 at 2:15 PM
- Evaluation of Sperm Quality Tests in IUI Success – Kristin Brogaard, PhD, 10/22 at 11:30 AM
- Obesity’s Impact on Frozen Embryo Transfer Outcomes – Amanda Kadesh, MD, MS, 10/21 at 3:30 PM
Special Sessions and Events:
The congress will also feature various roundtables, symposia, and interactive sessions focusing on topics such as optimizing sperm selection and evidence-based evaluations of recurrent pregnancy loss.
IVI RMA North America’s extensive research efforts reflect its ongoing commitment to revolutionizing infertility care through innovation and enhanced clinical practices.
About IVI RMA North America
IVI RMA North America, comprising Reproductive Medicine Associates, Boston IVF, and Toronto-based TRIO, spans 35+ IVF laboratories and has helped women achieve pregnancies which have led to the birth of over 300,000 babies to date. Pioneers in innovative care, including PGT-A, single embryo transfer, fertility preservation, LGBTQ+ care, and more, the network has published over 1,000 papers which have pushed the fertility industry forward. The network has affiliations with several academic institutions across the country, including Harvard Medical School, Beth Israel Deaconess Medical Center and Sidney Kimmel Medical College at Thomas Jefferson University.
